Skip to main content
Equibles

INGALLS & SNYDER LLC

Position in HYFT — MindWalk Holdings Corp.

CIK 1041885 NEW YORK, NY
Back to HYFT Full portfolio

Position in HYFT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,796,056
+$1,511,101 QoQ
Shares Held
3,035,479
+4.4% QoQ
Ownership
6.44%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1
of 27 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HYFT Over Time

Shares Held

Position Value (USD)

Derivatives in HYFT

reported options exposure · as of Dec 31, 2025
CallValue
$603,330
CallShares
331,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

INGALLS & SNYDER LLC holds $733,965,925 across 13 Biotechnology names. HYFT ranks #3 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CORT
Corcept Therapeutics Inc
 7,934,507 $689,905,383
2 OMER
Omeros Corp
 3,659,523 $34,802,063
3 HYFT
MindWalk Holdings Corp.
This page 		3,035,479 $4,796,056
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,903 $1,442,007
5 GMAB
Genmab A/S
 50,841 $1,396,602
6 HALO
Halozyme Therapeutics, Inc.
 7,339 $574,423
7 EPRX
Eupraxia Pharmaceuticals Inc.
 68,450 $452,454
8 VCEL
Vericel Corp
 5,000 $222,450

All Filings in HYFT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,796,056 3,035,479
2026-03-31 $3,284,955 2,907,040
2025-12-31 $4,967,002 2,729,122
2025-12-31 $603,330 331,500
2025-09-30 $4,724,457 2,699,690
2025-09-30 $175,000 100,000